FDA Inspection 1019488 — Central Iowa Health System
The FDA completed an inspection of Central Iowa Health System on June 28, 2017 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Des Moines, IA (United States)